The Cancer Research UK (CRUK) International Accelerator Award supports large‑scale, multidisciplinary cancer research programmes that bring together leading researchers from the UK and partner countries to address major unanswered questions in cancer. The scheme is specifically designed to accelerate progress by combining complementary expertise, resources, and patient populations across borders. Oncology projects are eligible across the full spectrum of cancer research, including cancer biology, early detection, prevention, translational research, and population sciences. CRUK strongly encourages partnerships involving low‑ and middle‑income countries, particularly in Africa, where cancer burden is rising and research capacity building is a key objective.
Eligibility Criteria:
Applicants must:
- Be based at an eligible academic or non‑profit research institution
- Apply as part of a UK‑led international consortium
- Demonstrate complementary expertise between UK and international partners
- Propose a cancer research programme with clear added value from international collaboration
- Show potential for significant scientific or translational impact
There are no citizenship restrictions. International partner institutions may be based in Europe, Africa, Australia, or other regions.
Funding Details:
- Total funding: Up to £20 million per award (programme‑dependent)
- Funding duration: Up to 6 years
- Covers research staff, consumables, equipment, data generation, and collaboration costs
- Funding levels determined by scientific scope and consortium size
Deadline:
- Expression of Interest (EOI) deadline: Mid‑2026 (exact date specified in call guidance)
- Full application by invitation only following EOI review
Where to go for further information:
- Programme page
- Application system: CRUK Grant Management System (GMS)
- Contact: internationalfunding@cancer.org.uk